Pancreatic Cancer Clinical Trials

Showing 441-460 of 1,019 trials

Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions

NCT04324294

The purpose of this study is to determine whether quantitative contrast-enhanced endoscopic ultrasound (CE-EUS) improves the evaluation of pancreas tumors and precursor lesions, including cysts, compared to conventional endoscopic ultrasound.

PancreatitisPancreas CancerPancreas Cyst

Cedars-Sinai Medical Center200 participantsStarted Feb 2020

Los Angeles, California, United States

RECRUITINGPhase 2

Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)

NCT06159478

This study is an open-label, parallel, 2-cohort, multicenter, investigator-initiated Phase 2 trial to evaluate the efficacy and safety of binimetinib in patients with advanced or recurrent low-grade glioma or pancreatic cancer harboring BRAF fusion/rearrangement.

Low-grade GliomaPancreatic Cancer

National Cancer Center, Japan32 participantsStarted Mar 2023

Kashiwa, Chiba, Japan • Sapporo, Hokkaido, Japan • Kyoto, Kyoto, Japan +3 more locations

RECRUITINGNA

Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer

NCT05424159

The aim of this study is to investigate the clinical efficacy and safety of ablative carbon ion radiotherapy for locally advanced unresectable pancreatic cancer with pencil beam scanning and simultaneous integrated boost (SIB) technology.

Pancreatic Cancer Non-resectable

Shanghai Proton and Heavy Ion Center48 participantsStarted Jul 2022

Shanghai, China

Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions

Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)

Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer

Related Searches

Clinical Utility Study for Exo-PDAC

Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino

LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic Cancer

OH2 Oncolytic Viral Therapy in Pancreatic Cancer

Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer

Bemalenograstim Alfa for the Prevention in Patients With Colorectal Cancer/Pancreatic Cancer

A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors

Quality of Life of Pancreatic Cancer Patients:Psychometric Validation of Chinese Version in Taiwan

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer

Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer

COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer

Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas

Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer

Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer

Proglumide With Gemcitabine and Nab-Paclitaxel in PatientsWith Metastatic Pancreatic Ductal Adenocarcinoma

Clinical Trial of Pancreatic Cancer in Stockholm.